Brussels - Delayed Quote EUR
Hyloris Pharmaceuticals SA (HYL.BR)
6.30
-0.05
(-0.74%)
At close: April 25 at 5:19:10 PM GMT+2
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
47,681
60,728
63,444
69,182
Total Liabilities Net Minority Interest
8,612
6,819
15,388
10,123
Total Equity Gross Minority Interest
39,069
53,909
48,056
59,059
Total Capitalization
39,069
53,909
48,056
66,944
Common Stock Equity
39,069
53,909
48,056
59,059
Capital Lease Obligations
1,751
885
174
152
Net Tangible Assets
35,241
50,302
45,112
56,678
Working Capital
28,549
44,029
38,981
64,481
Invested Capital
39,069
53,909
48,056
67,353
Tangible Book Value
35,241
50,302
45,112
56,678
Total Debt
1,751
885
174
8,446
Share Issued
28,000.37
28,000.37
25,832.63
25,832.63
Ordinary Shares Number
28,000.37
28,000.37
25,832.63
25,832.63
12/31/2020 - 6/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDD.F Innate Pharma S.A.
1.7460
+0.58%
TUB.BR Financière de Tubize SA
118.40
+1.72%
BIOS.BR BioSenic S.A.
0.0013
0.00%
CYAD.BR Celyad Oncology SA
0.4810
+0.21%
ARGX.BR argenx SE
535.80
+0.79%
ONWD.BR Onward Medical N.V.
4.0150
-0.12%
GLPG.AS Galapagos NV
23.40
+1.83%
UCB.BR UCB SA
149.70
+2.57%
INVA Innoviva, Inc.
18.24
-0.76%
ITOS iTeos Therapeutics, Inc.
7.35
-1.47%